Pharmaceutical Technology and Biopharmacy

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmaceutical Technology and Biopharmacy

Contact information

A Deusinglaan1
9713 AV
  • Phone: +31 50 363 3284
  • Fax: +31 50 363 2500
  1. The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn's Disease

    Mortensen, J. H., van Haaften, W. T., Karsdal, M. A., Bay-Jensen, A-C., Olinga, P., Grønbæk, H., Hvas, C. L., Manon-Jensen, T., Dijkstra, G. & Dige, A., 14-Apr-2020, In : Journal of clinical gastroenterology.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Survival and cellular heterogeneity of epithelium in cultured mouse and rat precision-cut intestinal slices

    Biel, C., Bigaeva, E., Hesse, M., Bomers, J. J. M., van Summeren, K., Teunis, M. A. T., Vaessen, S., Ten Klooster, J. P. & Olinga, P., Dec-2020, In : Toxicology in Vitro. 69, 104974.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (712) »

  1. Dataset: Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice

    Amssoms, K. (Creator), Born, P. (Creator), Beugeling, M. (Creator), De Clerck, B. (Creator), Van Gulck, E. (Creator), Hinrichs, W. (Creator), Frijlink, E. (Creator), Grasmeijer, N. (Creator), Kraus, G. (Creator), Sutmuller, R. (Creator), Simmen, K. (Creator) & Baert, L. (Creator), University of Groningen, 17-Aug-2018


View all (1) »

  1. Astellas Foundation 2008-2009

    Frijlink, Erik (Recipient), 2008


  2. Wubbo Ockels Price

    Boer, de, Anne (Recipient), 2010


View all (4) »

  1. Human ex vivo models for liver disease

    Peter Olinga (Keynote speaker)


    Activity: Talk or presentationAcademic

  2. Drug targeting meets liver fibrosis

    Peter Olinga (Invited speaker)


    Activity: Talk or presentationAcademic

  3. Ins and out of Inhalation Therapy

    Paul Hagedoorn (Invited speaker)


    Activity: Participating in or organising an eventParticipation in conferenceAcademic

View all (21) »

Press / Media
  1. Oplossing voor niet langer leverbare Rhinocort Turbuhaler

    Paul Hagedoorn


    1 Media contribution

    Press/Media: Public Engagement ActivitiesProfessional

  2. Proefdiervrij moet betrouwbaardere en waardevollere wetenschap opleveren

    Henri Leuvenink & Peter Olinga


    1 item of Media coverage

    Press/Media: Public Engagement ActivitiesProfessional

  3. UMCG werkt aan vaccin om alle griepen de wereld uit te helpen

    H.W. Frijlink


    1 Media contribution

    Press/Media: ResearchPopular

View all (10) »

ID: 32615